TY - JOUR
T1 - Integrated analysis of unclassified variants in mismatch repair genes
AU - Pastrello, Chiara
AU - Pin, Elisa
AU - Marroni, Fabio
AU - Bedin, Chiara
AU - Fornasarig, Mara
AU - Tibiletti, Maria Grazia
AU - Oliani, Cristina
AU - De Leon, Maurizio Ponz
AU - Urso, Emanuele Damiano
AU - Puppa, Lara Della
AU - Agostini, Marco
AU - Viel, Alessandra
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2011/2
Y1 - 2011/2
N2 - Purpose: Lynch syndrome is a genetic disease that predisposes to colorectal tumors, caused by mutation in mismatch repair genes. The use of genetic tests to identify mutation carriers does not always give perfectly clear results, as happens when an unclassified variant is found. This study aimed to define the pathogenic role of 35 variants present in MSH2, MLH1, MSH6, and PMS2 genes identified in our 15-year case study. Methods: We collected clinical and molecular data of all carriers, and then we analyzed the variants pathogenic role with web tools and molecular analyses. Using a Bayesian approach, we derived a posterior probability of pathogenicity and classified each variant according to a standardized five-class system. Results: The MSH2 p.Pro349Arg, p.Met688Arg, the MLH1 p.Gly67Arg, p.Thr82Ala, p.Lys618Ala, the MSH6 p.Ala1236Pro, and the PMS2 p.Arg20Gln were classified as pathogenic, and the MSH2 p.Cys697Arg and the PMS2 p.Ser46Ile were classified as likely pathogenic. Seven variants were likely nonpathogenic, 3 were nonpathogenic, and 16 remained uncertain. CONCLUSION:: Quantitative assessment of several parameters and their integration in a multifactorial likelihood model is the method of choice for classifying the variants. As such classifications can be associated with surveillance and testing recommendations, the results and the method developed in our study can be useful for helping laboratory geneticists in evaluation of genetic tests and clinicians in the management of carriers.
AB - Purpose: Lynch syndrome is a genetic disease that predisposes to colorectal tumors, caused by mutation in mismatch repair genes. The use of genetic tests to identify mutation carriers does not always give perfectly clear results, as happens when an unclassified variant is found. This study aimed to define the pathogenic role of 35 variants present in MSH2, MLH1, MSH6, and PMS2 genes identified in our 15-year case study. Methods: We collected clinical and molecular data of all carriers, and then we analyzed the variants pathogenic role with web tools and molecular analyses. Using a Bayesian approach, we derived a posterior probability of pathogenicity and classified each variant according to a standardized five-class system. Results: The MSH2 p.Pro349Arg, p.Met688Arg, the MLH1 p.Gly67Arg, p.Thr82Ala, p.Lys618Ala, the MSH6 p.Ala1236Pro, and the PMS2 p.Arg20Gln were classified as pathogenic, and the MSH2 p.Cys697Arg and the PMS2 p.Ser46Ile were classified as likely pathogenic. Seven variants were likely nonpathogenic, 3 were nonpathogenic, and 16 remained uncertain. CONCLUSION:: Quantitative assessment of several parameters and their integration in a multifactorial likelihood model is the method of choice for classifying the variants. As such classifications can be associated with surveillance and testing recommendations, the results and the method developed in our study can be useful for helping laboratory geneticists in evaluation of genetic tests and clinicians in the management of carriers.
KW - colorectal cancer
KW - Lynch syndrome
KW - mismatch repair
KW - multifactorial likelihood
KW - unclassified variant
UR - http://www.scopus.com/inward/record.url?scp=79951575821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951575821&partnerID=8YFLogxK
U2 - 10.1097/GIM.0b013e3182011489
DO - 10.1097/GIM.0b013e3182011489
M3 - Article
C2 - 21239990
AN - SCOPUS:79951575821
VL - 13
SP - 115
EP - 124
JO - Genetics in Medicine
JF - Genetics in Medicine
SN - 1098-3600
IS - 2
ER -